Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.800
+0.032 (4.22%)
At close: Mar 9, 2026, 4:00 PM EDT
0.820
+0.020 (2.50%)
After-hours: Mar 9, 2026, 5:47 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $28.95 million as of March 9, 2026. Its market cap has decreased by -34.80% in one year.
Market Cap
28.95M
Enterprise Value
25.08M
1-Year Change
-34.80%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $28.95M, a decrease of -69.46%. That is a compound annual growth rate of -15.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 27.80M | -18.24% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 29.40M |
| RenovoRx | 28.96M |
| NeuroSense Therapeutics | 28.92M |
| Kyntra Bio | 27.67M |
| BriaCell Therapeutics | 27.53M |
| IGC Pharma | 27.39M |
| Cue Biopharma | 27.35M |
| Evaxion | 26.86M |